John Michael Langlands - Net Worth and Insider Trading
John Michael Langlands Net Worth
The estimated net worth of John Michael Langlands is at least $4,000 dollars as of 2024-11-10. John Michael Langlands is the Senior Officer of Rakovina Therapeutics Inc and owns about 50,000 shares of Rakovina Therapeutics Inc (TSXV:RKV) stock worth over $4,000. Details can be seen in John Michael Langlands's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Michael Langlands has not made any transactions after 2022-12-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Michael Langlands
John Michael Langlands Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Michael Langlands owns 1 companies in total, including Rakovina Therapeutics Inc (TSXV:RKV) .
Click here to see the complete history of John Michael Langlands’s form 4 insider trades.
Insider Ownership Summary of John Michael Langlands
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSXV:RKV | Rakovina Therapeutics Inc | 2022-12-28 | Senior Officer |
John Michael Langlands Latest Holdings Summary
John Michael Langlands currently owns a total of 1 stock. John Michael Langlands owns 50,000 shares of Rakovina Therapeutics Inc (TSXV:RKV) as of December 28, 2022, with a value of $4,000.
Latest Holdings of John Michael Langlands
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSXV:RKV | Rakovina Therapeutics Inc | 2022-12-28 | 50,000 | 0.08 | 4,000 |
Holding Weightings of John Michael Langlands
John Michael Langlands Form 4 Trading Tracker
According to the SEC Form 4 filings, John Michael Langlands has made a total of 1 transactions in Rakovina Therapeutics Inc (TSXV:RKV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rakovina Therapeutics Inc is the acquisition of 50,000 shares on December 28, 2022, which cost John Michael Langlands around $9,000.
Insider Trading History of John Michael Langlands
- 1
John Michael Langlands Trading Performance
GuruFocus tracks the stock performance after each of John Michael Langlands's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Michael Langlands is -25%. GuruFocus also compares John Michael Langlands's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Michael Langlands within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Michael Langlands's insider trading performs compared to the benchmark.
Performance of John Michael Langlands
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.11 | | | | | |
| Relative Return to S&P 500(%) | -18.71 | | | | | |
John Michael Langlands Ownership Network
Ownership Network List of John Michael Langlands
Ownership Network Relation of John Michael Langlands
John Michael Langlands Owned Company Details
What does Rakovina Therapeutics Inc do?
Who are the key executives at Rakovina Therapeutics Inc?
John Michael Langlands is the Senior Officer of Rakovina Therapeutics Inc. Other key executives at Rakovina Therapeutics Inc include Senior Officer Jeffrey Bacha , Senior Officer Mads Daugaard , and Director & Senior Officer Alfredo De Lucrezia .
Rakovina Therapeutics Inc (TSXV:RKV) Insider Trades Summary
Over the past 18 months, John Michael Langlands made no insider transaction in Rakovina Therapeutics Inc (TSXV:RKV). Other recent insider transactions involving Rakovina Therapeutics Inc (TSXV:RKV) include a net purchase of 170,000 shares made by Jeffrey Bacha , a net purchase of 107,143 shares made by Alfredo De Lucrezia , and a net purchase of 25,000 shares made by Mads Daugaard .
In summary, during the past 3 months, insiders sold 0 shares of Rakovina Therapeutics Inc (TSXV:RKV) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 0 shares of Rakovina Therapeutics Inc (TSXV:RKV) were sold and 302,143 shares were bought by its insiders, resulting in a net purchase of 302,143 shares.
Rakovina Therapeutics Inc (TSXV:RKV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rakovina Therapeutics Inc Insider Transactions
John Michael Langlands Mailing Address
Above is the net worth, insider trading, and ownership report for John Michael Langlands. Currently GuruFocus does not have mailing address information for John Michael Langlands.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
